GlobalData on MSN7d
Roche’s discontinued Alzheimer’s drug shows signs of preventing onsetInvestigators said that the OLE study showed Roche’s gantenerumab dropped the risk of developing symptoms by 50%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback